Compile Data Set for Download or QSAR
Report error Found 46 of affinity data for UniProtKB/TrEMBL: Q9ULC6
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50447760(CHEMBL58150)
Affinity DataIC50: 70nMAssay Description:Inhibition of recombinant wild-type PAD1 (unknown origin) using N-alpha-Benzoyl-L-arginine amide as substrate preincubated for 15 mins followed by su...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2014
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50355657(CHEMBL1962361 | CHEMBL1910972)
Affinity DataIC50: 800nMAssay Description:Irreversible inhibition of PAD1 assessed as hydrolysis of benzoyl-L-arginine ethyl ester preincubated for 15 mins measured after 15 mins by fluoromet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50355665(CHEMBL1910971)
Affinity DataIC50: 840nMAssay Description:Irreversible inhibition of PAD1 assessed as hydrolysis of benzoyl-L-arginine ethyl ester preincubated for 15 mins measured after 15 mins by fluoromet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50447757(CHEMBL57818)
Affinity DataIC50: 950nMAssay Description:Inhibition of recombinant wild-type PAD1 (unknown origin) using N-alpha-Benzoyl-L-arginine amide as substrate preincubated for 15 mins followed by su...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2014
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50447761(CHEMBL60908)
Affinity DataIC50: 960nMAssay Description:Inhibition of recombinant wild-type PAD1 (unknown origin) using N-alpha-Benzoyl-L-arginine amide as substrate preincubated for 15 mins followed by su...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2014
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50355656(CHEMBL1910970)
Affinity DataIC50: 1.40E+3nMAssay Description:Irreversible inhibition of PAD1 assessed as hydrolysis of benzoyl-L-arginine ethyl ester preincubated for 15 mins measured after 15 mins by fluoromet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50447759(CHEMBL3113470)
Affinity DataIC50: 2.27E+3nMAssay Description:Inhibition of recombinant wild-type PAD1 (unknown origin) using N-alpha-Benzoyl-L-arginine amide as substrate preincubated for 15 mins followed by su...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2014
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM80075(7-bromo-6-methoxyquinoline-5,8-dione | cid_265935 ...)
Affinity DataIC50: 4.55E+3nMAssay Description:Inhibition of recombinant wild-type PAD1 (unknown origin) using N-alpha-Benzoyl-L-arginine amide as substrate preincubated for 15 mins followed by su...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2014
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50581394(CHEMBL5093554)
Affinity DataIC50: 8.50E+3nMAssay Description:Inhibition of PAD1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50355656(CHEMBL1910970)
Affinity DataKi:  9.40E+3nMAssay Description:Irreversible inhibition of PAD1 assessed as hydrolysis of benzoyl-L-arginine ethyl ester preincubated for 15 mins measured after 15 mins by fluoromet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50355658(CHEMBL1910973)
Affinity DataIC50: 2.90E+4nMAssay Description:Irreversible inhibition of PAD1 assessed as hydrolysis of benzoyl-L-arginine ethyl ester preincubated for 15 mins measured after 15 mins by fluoromet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50535204(CHEMBL4468883)
Affinity DataIC50: 3.40E+4nMAssay Description:Inhibition of recombinant human 6His-tagged PAD1 assessed as reduction in residual activity preincubated for 15 mins followed by addition of N-benzoy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2021
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50447758(CHEBI:9287 | NSC-45383 | Nigrin | Rufocromomycin |...)
Affinity DataIC50: 4.83E+4nMAssay Description:Inhibition of recombinant wild-type PAD1 (unknown origin) using N-alpha-Benzoyl-L-arginine amide as substrate preincubated for 15 mins followed by su...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2014
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50535205(CHEMBL4461562)
Affinity DataIC50: 5.20E+4nMAssay Description:Inhibition of recombinant human 6His-tagged PAD1 assessed as reduction in residual activity preincubated for 15 mins followed by addition of N-benzoy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2021
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50355657(CHEMBL1962361 | CHEMBL1910972)
Affinity DataKi:  6.20E+4nMAssay Description:Irreversible inhibition of PAD1 assessed as hydrolysis of benzoyl-L-arginine ethyl ester preincubated for 15 mins measured after 15 mins by fluoromet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM454160(US10716791, Code KP-224)
Affinity DataKi:  6.40E+4nMAssay Description:Materials: PAD1, PAD2, PAD3 and PAD4 were purchased from commercial sources. Assay buffer: 50 mM Tris pH 7.5, 100 mM NaCl, 10 mM CaCl2, 5 mM DTT. Col...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM454161(US10716791, Code KP-226)
Affinity DataKi:  6.46E+4nMAssay Description:Materials: PAD1, PAD2, PAD3 and PAD4 were purchased from commercial sources. Assay buffer: 50 mM Tris pH 7.5, 100 mM NaCl, 10 mM CaCl2, 5 mM DTT. Col...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50535206(CHEMBL4464539)
Affinity DataIC50: 8.00E+4nMAssay Description:Inhibition of recombinant human 6His-tagged PAD1 assessed as reduction in residual activity preincubated for 15 mins followed by addition of N-benzoy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2021
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50355658(CHEMBL1910973)
Affinity DataKi:  1.10E+5nMAssay Description:Irreversible inhibition of PAD1 assessed as hydrolysis of benzoyl-L-arginine ethyl ester preincubated for 15 mins measured after 15 mins by fluoromet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM454175(US10716791, Code KP-314)
Affinity DataKi:  1.12E+5nMAssay Description:Materials: PAD1, PAD2, PAD3 and PAD4 were purchased from commercial sources. Assay buffer: 50 mM Tris pH 7.5, 100 mM NaCl, 10 mM CaCl2, 5 mM DTT. Col...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50246191(CHEMBL4089260)
Affinity DataKi:  1.12E+5nMAssay Description:Inhibition of full length human GST-tagged PAD1 expressed in baculovirus infected Sf9 insect cells preincubated for 30 mins followed by substrate add...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50535203(CHEMBL4473416)
Affinity DataIC50: 1.25E+5nMAssay Description:Inhibition of recombinant human 6His-tagged PAD1 assessed as reduction in residual activity preincubated for 15 mins followed by addition of N-benzoy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2021
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM454172(US10716791, Code KP-305)
Affinity DataKi:  1.47E+5nMAssay Description:Materials: PAD1, PAD2, PAD3 and PAD4 were purchased from commercial sources. Assay buffer: 50 mM Tris pH 7.5, 100 mM NaCl, 10 mM CaCl2, 5 mM DTT. Col...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM454169(US10716791, Code KP-302 | BDBM50246180)
Affinity DataKi:  1.55E+5nMAssay Description:Inhibition of full length human GST-tagged PAD1 expressed in baculovirus infected Sf9 insect cells preincubated for 30 mins followed by substrate add...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50535207(CHEMBL4449566)
Affinity DataIC50: 1.61E+5nMAssay Description:Inhibition of recombinant human 6His-tagged PAD1 assessed as reduction in residual activity preincubated for 15 mins followed by addition of N-benzoy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2021
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50535208(CHEMBL4547728)
Affinity DataIC50: 2.94E+5nMAssay Description:Inhibition of recombinant human 6His-tagged PAD1 assessed as reduction in residual activity preincubated for 15 mins followed by addition of N-benzoy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2021
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM454164(US10716791, Code KP-288 | BDBM50246192)
Affinity DataKi:  3.53E+5nMAssay Description:Inhibition of full length human GST-tagged PAD1 expressed in baculovirus infected Sf9 insect cells preincubated for 30 mins followed by substrate add...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50248829(CHEMBL4084229)
Affinity DataKi:  3.84E+5nMAssay Description:Inhibition of human PAD1 using BAEE as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by colorimetric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/15/2019
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM454170(US10716791, Code KP-303)
Affinity DataKi:  3.92E+5nMAssay Description:Materials: PAD1, PAD2, PAD3 and PAD4 were purchased from commercial sources. Assay buffer: 50 mM Tris pH 7.5, 100 mM NaCl, 10 mM CaCl2, 5 mM DTT. Col...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM454169(US10716791, Code KP-302 | BDBM50246180)
Affinity DataKi:  4.02E+5nMAssay Description:Materials: PAD1, PAD2, PAD3 and PAD4 were purchased from commercial sources. Assay buffer: 50 mM Tris pH 7.5, 100 mM NaCl, 10 mM CaCl2, 5 mM DTT. Col...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50535202(CHEMBL4546087)
Affinity DataIC50: 4.08E+5nMAssay Description:Inhibition of recombinant human 6His-tagged PAD1 assessed as reduction in residual activity preincubated for 15 mins followed by addition of N-benzoy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2021
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50426302(CHEMBL2312698)
Affinity DataKi:  4.45E+5nMAssay Description:Inhibition of human PAD1 using BAEE as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by colorimetric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/15/2019
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50535201(CHEMBL4442207)
Affinity DataIC50: 5.00E+5nMAssay Description:Inhibition of recombinant human 6His-tagged PAD1 assessed as reduction in residual activity preincubated for 15 mins followed by addition of N-benzoy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2021
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50248824(CHEMBL4059499)
Affinity DataKi:  6.02E+5nMAssay Description:Inhibition of human PAD1 using BAEE as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by colorimetric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/15/2019
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM454167(US10716791, Code KP-298)
Affinity DataKi:  7.85E+5nMAssay Description:Materials: PAD1, PAD2, PAD3 and PAD4 were purchased from commercial sources. Assay buffer: 50 mM Tris pH 7.5, 100 mM NaCl, 10 mM CaCl2, 5 mM DTT. Col...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM454164(US10716791, Code KP-288 | BDBM50246192)
Affinity DataKi:  9.14E+5nMAssay Description:Materials: PAD1, PAD2, PAD3 and PAD4 were purchased from commercial sources. Assay buffer: 50 mM Tris pH 7.5, 100 mM NaCl, 10 mM CaCl2, 5 mM DTT. Col...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM454162(BDBM50246174 | US10716791, Code KP-286)
Affinity DataKi:  9.64E+5nMAssay Description:Inhibition of full length human GST-tagged PAD1 expressed in baculovirus infected Sf9 insect cells preincubated for 30 mins followed by substrate add...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM454174(US10716791, Code KP-313)
Affinity DataKi:  1.09E+6nMAssay Description:Materials: PAD1, PAD2, PAD3 and PAD4 were purchased from commercial sources. Assay buffer: 50 mM Tris pH 7.5, 100 mM NaCl, 10 mM CaCl2, 5 mM DTT. Col...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50246193(CHEMBL4061099)
Affinity DataKi:  1.09E+6nMAssay Description:Inhibition of full length human GST-tagged PAD1 expressed in baculovirus infected Sf9 insect cells preincubated for 30 mins followed by substrate add...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50248814(CHEMBL4070114)
Affinity DataKi:  2.42E+6nMAssay Description:Inhibition of human PAD1 using BAEE as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by colorimetric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/15/2019
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM454162(BDBM50246174 | US10716791, Code KP-286)
Affinity DataKi:  2.50E+6nMAssay Description:Materials: PAD1, PAD2, PAD3 and PAD4 were purchased from commercial sources. Assay buffer: 50 mM Tris pH 7.5, 100 mM NaCl, 10 mM CaCl2, 5 mM DTT. Col...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM454173(US10716791, Code KP-310)
Affinity DataKi:  3.43E+6nMAssay Description:Materials: PAD1, PAD2, PAD3 and PAD4 were purchased from commercial sources. Assay buffer: 50 mM Tris pH 7.5, 100 mM NaCl, 10 mM CaCl2, 5 mM DTT. Col...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM454163(BDBM50246172 | US10716791, Code KP-287)
Affinity DataKi: >1.00E+7nMAssay Description:Inhibition of full length human GST-tagged PAD1 expressed in baculovirus infected Sf9 insect cells preincubated for 30 mins followed by substrate add...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50246194(CHEMBL4062179 | US10716791, Example KP-316)
Affinity DataKi: >1.00E+7nMAssay Description:Inhibition of full length human GST-tagged PAD1 expressed in baculovirus infected Sf9 insect cells preincubated for 30 mins followed by substrate add...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50246179(CHEMBL4081389)
Affinity DataKi: >1.00E+7nMAssay Description:Inhibition of full length human GST-tagged PAD1 expressed in baculovirus infected Sf9 insect cells preincubated for 30 mins followed by substrate add...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2019
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-1(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50246194(CHEMBL4062179 | US10716791, Example KP-316)
Affinity DataKi:  7.77E+7nMAssay Description:Materials: PAD1, PAD2, PAD3 and PAD4 were purchased from commercial sources. Assay buffer: 50 mM Tris pH 7.5, 100 mM NaCl, 10 mM CaCl2, 5 mM DTT. Col...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent